Along with GLP-1R (glucagon-like peptide 1 receptor) and GIPR (gastric inhibitory polypeptide receptor), it is one of the critical receptors that regulate glucose homeostasis
Others transition to alternative strategies or medications based on their individual goals
Moreover, due to the peripheral action of GLP-1, their use in depressed patients may also prevent the development of metabolic diseases, such as diabetes and obesity, which are often associated with a depressive disorder
Optimize timing of fluid intake around medication administration and meals
A recent trial on the treatment effect of semaglutide in people with obesity reported the significant effects of the long-acting GLP-1RA semaglutide on body weight and related phenotypes (169)
The portal allows you to log not only your weight but also key body measurements, such as waist, hip, and neck circumference